Topoisomerase II (TOP2)
Assets acting on this target.
- Class
- Topoisomerase II inhibitor (anthracenedione antineoplastic)
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT07490288
Related mechanisms